EGFR and neoplasm: This improvement may be attributed to the heightened radiosensitivity of EGFR-positive NSCLC cells and the ability of cranial RT to efficiently clear intracranial tumours while potentially facilitating better EGFR-TKI penetration through the blood–brain barrier.